Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in MyoCardial Infarction (AMICI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01781390
Recruitment Status : Active, not recruiting
First Posted : February 1, 2013
Last Update Posted : February 26, 2019
Sponsor:
Information provided by (Responsible Party):
Mesoblast, Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : July 17, 2018
Estimated Study Completion Date : April 2021
Certification/Extension First Submitted : February 24, 2019